These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33312891)

  • 1. Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?
    Piñero F; Thompson M; Marín JI; Silva M
    World J Transplant; 2020 Nov; 10(11):297-306. PubMed ID: 33312891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial.
    Himmelsbach V; Jeschke M; Lange CM; Scheiner B; Pinter M; Sinner F; Venerito M; Queck A; Trojan J; Waidmann O; Finkelmeier F
    Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study.
    Chen YY; Chen CL; Lin CC; Wang CC; Liu YW; Li WF; Chen YH
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario.
    Dipasquale A; Marinello A; Santoro A
    J Hepatocell Carcinoma; 2021; 8():241-251. PubMed ID: 33884259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.
    Doycheva I; Thuluvath PJ
    J Clin Exp Hepatol; 2019; 9(5):588-596. PubMed ID: 31695249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
    Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
    World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Systemic Treatments in Advanced Hepatocellular Carcinoma.
    Sanduzzi-Zamparelli M; Díaz-Gonzalez Á; Reig M
    Liver Transpl; 2019 Feb; 25(2):311-322. PubMed ID: 30317696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Sposito C; Cucchetti A; Mazzaferro V
    Dig Dis Sci; 2019 Apr; 64(4):1001-1007. PubMed ID: 30852770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control Study.
    Han B; Ding H; Zhao S; Zhang Y; Wang J; Zhang Y; Gu J
    Front Oncol; 2020; 10():562103. PubMed ID: 33365268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Future Systemic Therapies for Hepatocellular Carcinoma.
    Bteich F; Di Bisceglie AM
    Gastroenterol Hepatol (N Y); 2019 May; 15(5):266-272. PubMed ID: 31360140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors.
    Piñero F; Silva M; Iavarone M
    World J Gastroenterol; 2020 Apr; 26(16):1888-1900. PubMed ID: 32390700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation.
    Saleh Y; Abu Hejleh T; Abdelrahim M; Shamseddine A; Chehade L; Alawabdeh T; Mohamad I; Sammour M; Turfa R
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation.
    Pelizzaro F; Gambato M; Gringeri E; Vitale A; Cillo U; Farinati F; Burra P; Russo FP
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation.
    Guerrini GP; Berretta M; Tarantino G; Magistri P; Pecchi A; Ballarin R; Di Benedetto F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3421-3435. PubMed ID: 28829499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
    Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
    Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.
    Mody K; Abou-Alfa GK
    Curr Treat Options Oncol; 2019 Jan; 20(2):3. PubMed ID: 30635732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices.
    Rich NE; Parikh ND; Singal AG
    Curr Treat Options Gastroenterol; 2017 Jun; 15(2):296-304. PubMed ID: 28425018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
    Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
    Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.